HGC Investment Management’s Verona Pharma VRNA Stock Holding History

HGC Investment Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-73,890	Closed	-$7.88M	–	162
2025 Q3	$7.88M	Buy	+73,890	New	+$7.72M	1.92%	15

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

HGC Investment Management's VRNA Position: Q4 2025 in Review

HGC Investment Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 73,890 shares — an estimated $7.88M sold.

HGC Investment Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $7.88M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

HGC Investment Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
HGC Investment Management sold 73,890 Verona Pharma shares in Q4 2025, an estimated $7.88M.
HGC Investment Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
HGC Investment Management's Verona Pharma position peaked at $7.88M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on HGC Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.